Jennifer Kayden Lee

Insider Reports History

Entity
Individual
Location
C/O Krystal Biotech, Inc., 2100 Wharton Street, Suite 701, Pittsburgh, PA
Signature
/s/ Stephen Vander Stoep, Attorney-in-Fact for Jennifer Kayden Lee
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Kayden Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RHYTHM PHARMACEUTICALS, INC. EVP, Head of North America Restricted Stock Units 16.5K $944K $57.22 Feb 16, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. EVP, Head of North America Common Stock 5.86K $335K $57.22 Feb 19, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. EVP, Head of North America Stock Options (Right to Buy) 55K Feb 14, 2025 Direct
RHYTHM PHARMACEUTICALS, INC. EVP, Head of North America Stock Option (Right to Buy) 21.6K Feb 9, 2025 Direct

Insider Reports Filed by Jennifer Kayden Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 14, 2025 5 -$116K 4 Feb 19, 2025 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 12, 2025 4 -$172K 4 Feb 14, 2025 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 9, 2025 10 -$277K 4 Feb 11, 2025 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 5, 2025 3 -$186K 4 Feb 7, 2025 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 1, 2025 3 -$86K 4 Feb 4, 2025 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Nov 11, 2024 10 -$3.24M 4 Nov 13, 2024 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Mar 20, 2024 2 -$707K 4 Mar 22, 2024 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Mar 19, 2024 1 -$608K 4 Mar 19, 2024 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 16, 2024 3 $0 4 Feb 21, 2024 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 9, 2024 6 -$83.2K 4 Feb 13, 2024 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 1, 2024 3 -$67.2K 4 Feb 5, 2024 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Nov 14, 2023 3 -$356K 4 Nov 16, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Nov 8, 2023 8 -$198K 4 Nov 13, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Nov 3, 2023 3 -$1.7K 4 Nov 7, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Sep 5, 2023 3 -$142K 4 Sep 7, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Aug 7, 2023 6 -$244K 4 Aug 9, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 11, 2023 3 -$17.1K 4 Feb 14, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 9, 2023 1 -$33.1K 4/A Feb 14, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 1, 2023 2 $0 4 Feb 3, 2023 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 11, 2022 3 -$4.4K 4 Feb 15, 2022 EVP, Head of North America
RYTM RHYTHM PHARMACEUTICALS, INC. Feb 9, 2022 2 $0 4 Feb 11, 2022 EVP, Head of North America